Atea Pharmaceuticals (AVIR) Stock Chart & Stock Price History $3.38 -0.08 (-2.31%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$3.38 0.00 (-0.15%) As of 08/8/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Atea Pharmaceuticals Stock Price Performance The Atea Pharmaceuticals (AVIR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 0.30%, with a year-to-date return of 0.90%. In the past month, the stock has decreased 10.11%, reflecting recent market activity. As of the latest close, Atea Pharmaceuticals traded at $3.38 with a market cap of $289.26 million and volume of 302,702 shares. Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.25%1 Month Performance-10.11%3 Month Performance+24.26%Year-To-Date Performance+0.90%1 Year Performance+0.30% AVIR Stock Chart for Saturday, August, 9, 2025 AVIR Chart by TradingView Atea Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$3.46$3.38-2.31%$3.64$3.36302,702 shs$289.26 million08/07/2025$3.49$3.46-0.86%$3.56$3.44305,799 shs$296.10 million08/06/2025$3.52$3.49-0.85%$3.58$3.45339,540 shs$298.67 million08/05/2025$3.53$3.52-0.28%$3.56$3.51281,518 shs$301.24 million08/04/2025$3.47$3.53+1.73%$3.66$3.50315,501 shs$302.09 million08/01/2025$3.64$3.47-4.67%$3.69$3.46313,746 shs$296.96 million07/31/2025$3.67$3.64-0.82%$3.81$3.63285,380 shs$311.51 million07/30/2025$3.80$3.67-3.42%$3.97$3.64392,586 shs$314.08 million07/29/2025$3.79$3.80+0.26%$3.89$3.74257,812 shs$325.20 million07/28/2025$3.90$3.79-2.82%$4.02$3.78311,390 shs$324.35 million Get the Latest News and Ratings for AVIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$3.74$3.90+4.28%$3.92$3.71447,727 shs$333.76 million07/24/2025$3.49$3.74+7.16%$3.82$3.48421,658 shs$320.07 million07/23/2025$3.43$3.49+1.75%$3.52$3.44729,822 shs$298.67 million07/22/2025$3.43$3.43$3.49$3.42383,566 shs$293.54 million07/21/2025$3.36$3.43+2.08%$3.53$3.39394,963 shs$293.54 million07/18/2025$3.46$3.36-2.89%$3.52$3.36345,776 shs$287.55 million07/17/2025$3.49$3.46-0.86%$3.53$3.43388,027 shs$296.10 million07/16/2025$3.57$3.49-2.24%$3.74$3.46763,561 shs$298.67 million07/15/2025$3.76$3.57-5.05%$3.78$3.57335,838 shs$305.52 million07/14/2025$3.67$3.76+2.45%$3.79$3.66279,795 shs$321.78 million07/11/2025$3.78$3.67-2.91%$3.79$3.67311,695 shs$314.08 million07/10/2025$3.76$3.78+0.53%$3.83$3.75324,285 shs$323.49 million07/09/2025$3.65$3.76+3.01%$3.76$3.68378,725 shs$321.78 million07/08/2025$3.64$3.65+0.27%$3.76$3.65349,855 shs$312.37 million Related Companies Harrow Stock Price Chart Praxis Precision Medicines Stock Price Chart Avadel Pharmaceuticals Stock Price Chart Phibro Animal Health Stock Price Chart Pharvaris Stock Price Chart Ardelyx Stock Price Chart Structure Therapeutics Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart Verve Therapeutics Stock Price Chart Spyre Therapeutics Stock Price Chart Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVIR) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVIR Stock Alerts